HASBROUCK HEIGHTS, N.J., March 22, 2006 (PRIMEZONE) -- U.S. MedSys Corp. (OTCBB:UMSY) (The "Company") is pleased to announce that its subsidiary, Global Medical Direct (GMD), has executed an Ancillary Provider Contract, effective April 1, 2006, to supply mail order diabetic supplies to the membership of The Health Care Payers Coalition of New Jersey (HCPC). HCPC membership covers more than 150,000 New Jerseyans.
Ryan Leto of HCPC stated "We are very pleased to welcome Global Medical Direct to our network of quality health care providers. HCPC looks forward to a long relationship with GMD as we continue to provide professional heath care services and price savings to our membership."
Bob Shea, President of Global Medical Direct, stated "GMD is excited about working with a company with such an outstanding reputation as HCPC. We look forward to providing our diabetic services to their membership. At GMD we believe that with the combination of our services, educational support and price savings that we can provide HCPC membership who fight diabetes a convenient and cost effective way to deal with their disease."
Rosalind Piazza, COO/EVP of U.S. MedSys Corp., added "We are pleased to announce the forging of a new relationship with HCPC. HCPC represents the onset of potential labor healthcare business for U.S. MedSys Corp. We continue to strive for excellence in serving our end users and provide quality care and service to our members. We see this relationship as a perfect fit in expanding our position in the healthcare market."
About Health Care Payers Coalition of New Jersey:
The Health Care Payers Coalition of New Jersey is a health care purchasing cooperative for self-insured health plans that cover more than 150,000 New Jerseyans. Founded in 1992, HCPC promotes health care quality and emphasizes the empowerment of health care consumers by providing them with important information and education.
About Global Medical Direct
Global Medical Direct is a nationwide Durable Medical Equipment provider specializing in direct to consumer diabetes supplies. The Company provides diabetes products and educational services to help patients' lead healthier and more productive lives. Global Medical Direct provides an easy-to-use, cost effective and convenient way for patients to obtain their diabetes supplies and medications through their health plan, employer and government payors such as Medicare and Medicaid. The Company's products include blood glucose meters, test strips and ancillary supplies, insulin pumps and supplies, diabetic shoes and orthopedic inserts and diabetes maintenance medications.
About U.S. MedSys Corp.
U.S. MedSys Corp. is a medical network developer, marketing and distribution organization which provides support services and medical technology to the healthcare industry. U.S. MedSys Corp. is focusing on its core competencies in healthcare delivery, network development and marketing. The Company's purpose is to create a total platform that can be presented to healthcare providers as a means for Healthcare Administrators to cut costs without sacrificing quality of care to its membership. The UMSY business network consists of Global Medical Direct, a provider of sales, marketing and distribution of self-management products and services to patients with diabetes, PMC/Footcare, LLC, PMC Ocular, LLC and New England Orthotic and Diabetic Shoe Company (NEODS), which has been established to manufacture and market semi-custom orthotics, diabetic shoes and insoles. The company also markets its proprietary wound care program to the nursing home market.
Investors are encouraged to review company's filings available at www.sec.gov or at the company's website at www.usmedsyscorp.com
Safe Harbor Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of section 27A of the 1933 Securities Act and Section 21E of the Securities Exchange Act. Actual results could differ materially, as the result of such factors as competition in the markets for the company's products and services and the ability of the company to execute its plans. By making forward-looking statements, the company can give no assurances that the transactions described in this release will be successfully completed, and undertakes no obligation to update these statements for revisions or changes after the date of this press release.